Effectiveness, applicability and accessibility measure the value of novel technologies and therapies in oncology
Dario Trapani, Medical Oncologist at the European Institute of Oncology, shared a post by ESMO, on LinkedIn:
“Check out my latest column in ESMO Daily! I’m diving into innovation in oncology and making the case for why it must prioritize tackling cancer disparities. Let’s focus on impact where it’s needed most!”
Quoting ESMO‘s post:
“The latest article by Dario Trapani in the ESMO Daily Reporter highlights how together with effectiveness, applicability and accessibility measure the value of novel technologies and therapies in oncology.
From a health system’s perspective, innovation must not only improve lives, but it must be operationally feasible, highly effective and, most importantly, universally accessible. In his analysis he discusses how innovation is a double-edged sword, offering hope while carrying the risk of widening the inequity chasm, if innovative therapies remain accessible only in resource-rich settings, they just symbolise inequity.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023